Literature DB >> 12827141

Obsessive-compulsive disorder: development of demand-controlled deep brain stimulation with methods from stochastic phase resetting.

Peter A Tass1, Joachim Klosterkötter, Frank Schneider, Doris Lenartz, Anastasios Koulousakis, Volker Sturm.   

Abstract

Synchronization of neuronal firing is a hallmark of several neurological diseases. Recently, stimulation techniques have been developed which make it possible to desynchronize oscillatory neuronal activity in a mild and effective way, without suppressing the neurons' firing. As yet, these techniques are being used to establish demand-controlled deep brain stimulation (DBS) techniques for the therapy of movement disorders like severe Parkinson's disease or essential tremor. We here present a first conceptualization suggesting that the nucleus accumbens is a promising target for the standard, that is, permanent high-frequency, DBS in patients with severe and chronic obsessive-compulsive disorder (OCD). In addition, we explain how demand-controlled DBS techniques may be applied to the therapy of OCD in those cases that are refractory to behavioral therapies and pharmacological treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12827141     DOI: 10.1038/sj.npp.1300144

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  13 in total

1.  Diffusion tensor imaging in studying white matter complexity: a gap junction hypothesis.

Authors:  Chadi G Abdallah; Cheuk Y Tang; Sanjay J Mathew; Jose Martinez; Patrick R Hof; Tarique D Perera; Dikoma C Shungu; Jack M Gorman; Jeremy D Coplan
Journal:  Neurosci Lett       Date:  2010-04-03       Impact factor: 3.046

Review 2.  Network effects of deep brain stimulation.

Authors:  Ahmad Alhourani; Michael M McDowell; Michael J Randazzo; Thomas A Wozny; Efstathios D Kondylis; Witold J Lipski; Sarah Beck; Jordan F Karp; Avniel S Ghuman; R Mark Richardson
Journal:  J Neurophysiol       Date:  2015-08-12       Impact factor: 2.714

3.  Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease.

Authors:  E W Tsang; C Hamani; E Moro; F Mazzella; U Saha; A M Lozano; M Hodaie; R Chuang; T Steeves; S Y Lim; B Neagu; R Chen
Journal:  Neurology       Date:  2012-05-16       Impact factor: 9.910

4.  Phase resetting curves and oscillatory stability in interneurons of rat somatosensory cortex.

Authors:  T Tateno; H P C Robinson
Journal:  Biophys J       Date:  2007-01-15       Impact factor: 4.033

5.  [Technical innovations in deep brain stimulation].

Authors:  J Vesper; P J Slotty
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

6.  Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.

Authors:  Andrew Sharott; Alessandro Gulberti; Simone Zittel; Adam A Tudor Jones; Ulrich Fickel; Alexander Münchau; Johannes A Köppen; Christian Gerloff; Manfred Westphal; Carsten Buhmann; Wolfgang Hamel; Andreas K Engel; Christian K E Moll
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

7.  Clinical treatment of obsessive compulsive disorder.

Authors:  Christopher Pittenger; Ben Kelmendi; Michael Bloch; John H Krystal; Vladimir Coric
Journal:  Psychiatry (Edgmont)       Date:  2005-11

Review 8.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

9.  Low and High Gamma Oscillations in Rat Ventral Striatum have Distinct Relationships to Behavior, Reward, and Spiking Activity on a Learned Spatial Decision Task.

Authors:  Matthijs A A van der Meer; A David Redish
Journal:  Front Integr Neurosci       Date:  2009-06-11

10.  Nucleus Accumbens is Involved in Human Action Monitoring: Evidence from Invasive Electrophysiological Recordings.

Authors:  Thomas F Münte; Marcus Heldmann; Hermann Hinrichs; Josep Marco-Pallares; Ulrike M Krämer; Volker Sturm; Hans-Jochen Heinze
Journal:  Front Hum Neurosci       Date:  2008-03-28       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.